Michael G. King Jr. - CHIEF FINANCIAL OFFICER at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
SABS, SABSW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael G. King Jr. since 12 Mar 2025

Holdings reported by Michael G. King Jr. for SAB Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5,000 $4,400 $0.8800 30 Nov 2023 Direct
Employee Stock Option (right to buy) 115,000 21 Feb 2024 Direct Common Stock

Transactions reported by Michael G. King Jr. for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.